908 Devices
MASS908 Devices Inc. is a life sciences technology company that develops purpose-built handheld devices for point-of-need chemical analysis.
Earnings
Next report
Nov 9, 2026 (in a month)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
908 Devices Inc. is a life sciences technology company that develops purpose-built handheld devices for point-of-need chemical analysis. By leveraging miniaturized mass spectrometry and optical spectroscopy, the company provides front-line workers with the ability to identify unknown substances, including illicit drugs and toxic chemicals, in real-time. Their core value proposition lies in transforming complex laboratory-grade analytical technology into simple, rugged, and accessible tools for critical health, safety, and defense applications.
The company is a pioneer in the miniaturization of mass spectrometry, offering the first truly handheld devices in a market traditionally dominated by large, stationary laboratory instruments.
FAQ
- What is 908 Devices's market cap?
- 908 Devices (MASS) has a market capitalization of $517.1M and trades on NASDAQ.
- What is 908 Devices's revenue and profitability?
- 908 Devices generated $60.8M in trailing twelve-month revenue with a net loss of $34.7M, representing a net margin of -57.0%. Gross margin stands at 52.2%, with free cash flow of -$710.0K. The latest reported period is Q2 2026.
- Who are 908 Devices's competitors?
- 908 Devices's key competitors include Agilent Technologies, Inc., Waters Corporation, Thermo Fisher Scientific Inc., and others. These companies compete in similar markets and product categories.
- What subsidiaries does 908 Devices have?
- 908 Devices's subsidiaries include RedWave Technology.
- Where is 908 Devices headquartered?
- 908 Devices is headquartered in United States of America and employs approximately 230 people. It has been publicly traded since 2020.
